POWER OF KNOWLEDGE

Insight Center: News

Pepper Hamilton Closes More Than 90 Deals in 2018

Firm Represented Blue Chip Clients in Mergers and Acquisitions, Asset Purchases and Stock Purchases

1/31/2019
Pepper Hamilton Closes More Than 90 Deals in 2018

Pepper Hamilton LLP today announced results of the deals closed during the 2018 calendar year. The firm advised on more than 90 deals, with combined transaction values exceeding $10.5 billion, including cross-border deals in the United Kingdom, Canada and Turkey. The firm closed out the year strong, with Q4 bringing the highest number of overall deals as well as the highest total dollar value for deals.

Pepper Hamilton partners provided counsel to organizations across a variety of industries, including pharmaceutical, life sciences, medical devices, energy and utilities, insurance, software, manufacturing, technology, construction, financial services and more.

“2018 was a top-notch year for deal execution, with our attorneys bringing unparalleled market knowledge to the table and providing unmatched client service,” said Matthew Greenberg, chair of the Corporate and Securities Practice Group at Pepper Hamilton. “Our Corporate and Securities group consistently closed more than a dozen deals each quarter, providing our clients with innovative solutions for today’s marketplace.”

The firm’s Health Sciences Department also experienced a strong finish for the year, closing more than $1.1 billion in deals during Q4 alone.

“In today’s ever-evolving health sciences ecosystem, our clients need attorneys who deeply understand the complexities of the health care and life sciences industries,” said Rachael Bushey, vice chair of the Health Sciences Department and chair of Life Sciences at Pepper Hamilton. “In such highly regulated fields, these deals can pose significant risks if not structured properly. Our team helps clients expertly navigate these potential risks and structure deals in compliance with regulations, ensuring clients achieve their desired outcome. Our Q4 results, in particular, are a testament to this commitment.”

Roughly half of the deals closed by Pepper Hamilton in 2018 were private equity-related, which remained consistent per quarter.

“We are encouraged by the consistently strong performance of private equity-related deals throughout the year,” said Bruce Fenton, chair of the Private Equity Practice Group at Pepper Hamilton. “We are seeing deal activity remaining steady as we start 2019.”

Highlights of the 2018 transactions include:

  • AMETEK, Inc.’s multiple transactions, including its stock purchase of FMH Corporation and acquisition by merger of Telular Corporation and Spectro International Holdings. Lead partner – Deborah Spranger.

  • Marsh & McLennan Agency LLC’s multiple transactions, including its acquisitions of Otis-Magie Insurance Agency, Inc., Eustis Insurance & Benefits, Klein Agency, Inc., Insurance Associates, and Strategic Employee Benefits Services of San Diego. Lead partners – Brian Katz and James Jumper.

  • PeakEquity Partners’ investment in CareerArc Group. Lead partners – Bruce Fenton and Joseph Kadlec.

  • Special Committee of the Corporate Property Associates 17 Board for its merger with W.P. Carey. Lead attorney – Barry Abelson.

  • Harden Pharmacy’s (dba MBS Pharmacy) sale to CVS. Lead partner – John Jones.

  • GlaxoSmithKline’s out-license of a portfolio of five early-development programs to Boston Pharmaceuticals Inc. Lead partners – Rachael Bushey and Jennifer Porter.

  • Milestone Partners and its co-investors’ acquisition of mTAB LLC. Lead partners – Bruce Fenton and Daniel McDonough.

  • Susquehanna Growth Equity’s investment in PerkSpot. Lead partner – Matthew Greenberg.

  • OpenWave Mobility, Inc.’s sale to Enea Software AB. Lead partner – James Rosener.

  • SafeOp Surgical, Inc.’s merger with Alphatec Holdings Inc. Lead partner – Christopher Rossi.

  • New Enterprise Stone & Lime Co., Inc.’s asset purchase of Popple Construction, Inc. Lead partners – Brian Katz and Cary Levinson.

  • Graycliff Capital Partners’ stock purchase of Pebble Technology, Inc. Lead partner – Christopher Miller.

  • Evoqua Water Technologies’ stock purchase of ProAct Services Corporation. Lead partner – Eric Kline.

  • ProstaGene, LLC’s sale of assets to CytoDyn, Inc. Lead partner – Timothy Atkins.

  • DealerScience, LLC’s sale to TrueCar Dealer Solutions, Inc. Lead partners – Steven London and Nicholas Stawasz.

  • TSS Total Safety Services, Inc.’s purchases of Pivotal Safety Ltd. and Vantage Safety Services Ltd. Lead partner – James Epstein.

  • S.R. Smith, LLC’s asset purchase of Inter-Fab, Inc. Lead partners – Matthew Greenberg and Nilufer Shaikh.

  • XL Brands’ sale of assets to Bostik, Inc. Lead partner – Solomon Hunter.

  • Lesaffre Yeast Corporation’s asset purchase of Delavau L.L.C. Lead partner – Julia Corelli.

  • Ultimus Fund Solutions, LLC’s stock purchase of Woodfield Fund Administration, LLC. Lead partner – Thao Le.

  • Infinity Staffing Solutions LLC’s sale of assets to Lyneer Staffing Solutions, LLC. Lead partners – Michael Mann and Donald Readlinger.

  • Kordsa Inc.’s multiple transactions, including its stock purchase of Fabric Development, Inc. and Textile Products, Inc. and its stock purchase of Advanced Honeycomb Technologies Corporation. Lead partners – Michael Friedman and Brian Katz.

Data protection laws have changed, so we have revised our Privacy Policy.

CLOSE